Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial
- Written by PR Newswire Asia - Asian Spectator
MELBOURNE, Australia, April 8, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce the completion of patient enrolment in its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU).
CYP-006TK is...